Impact of the VIO system in hepatic resection for patients with hepatocellular carcinoma
Shinji Itoh(Kyushu University), Yoshihiko Maehara(Kyushu University), Kengo Fukuzawa(Oita Red Cross Hospital), Akinobu Taketomi(Hokkaido University), Masahiro Okamoto(Oita Red Cross Hospital), Yuki Shitomi(Oita Red Cross Hospital), Tadahiko Kinoshita, Kenzo Wakasugi(Oita Red Cross Hospital), Ken Shirabe(Gunma University)
Cited by 41
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244